<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK24701" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK24701/" /><meta name="ncbi_pagename" content="Mucolipidosis III Gamma - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Mucolipidosis III Gamma - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Mucolipidosis III Gamma" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/11/21" /><meta name="citation_author" content="Annick Raas-Rothschild" /><meta name="citation_author" content="Ronen Spiegel" /><meta name="citation_pmid" content="20301784" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK24701/" /><meta name="citation_keywords" content="N-acetylglucosamine-1-phosphotransferase subunit gamma" /><meta name="citation_keywords" content="GNPTG" /><meta name="citation_keywords" content="Mucolipidosis III Gamma" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Mucolipidosis III Gamma" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Annick Raas-Rothschild" /><meta name="DC.Contributor" content="Ronen Spiegel" /><meta name="DC.Date" content="2019/11/21" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK24701/" /><meta name="description" content="Mucolipidosis III gamma (ML IIIγ) is a slowly progressive inborn error of metabolism mainly affecting skeletal, joint, and connective tissues. Clinical onset is in early childhood; the progressive course results in severe functional impairment and significant morbidity from chronic pain. Cardiorespiratory complications (restrictive lung disease from thoracic involvement, and thickening and insufficiency of the mitral and aortic valves) are rarely clinically significant. A few (probably &lt;10%) affected individuals display mild cognitive impairment." /><meta name="og:title" content="Mucolipidosis III Gamma" /><meta name="og:type" content="book" /><meta name="og:description" content="Mucolipidosis III gamma (ML IIIγ) is a slowly progressive inborn error of metabolism mainly affecting skeletal, joint, and connective tissues. Clinical onset is in early childhood; the progressive course results in severe functional impairment and significant morbidity from chronic pain. Cardiorespiratory complications (restrictive lung disease from thoracic involvement, and thickening and insufficiency of the mitral and aortic valves) are rarely clinically significant. A few (probably &lt;10%) affected individuals display mild cognitive impairment." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK24701/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/ml3c/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK24701/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8C73A1E03F74A10000000007EB02E2.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK24701_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK24701_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ml3a/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ml4/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK24701_"><span class="title" itemprop="name">Mucolipidosis III Gamma</span></h1><p class="contrib-group"><span itemprop="author">Annick Raas-Rothschild</span>, MD and <span itemprop="author">Ronen Spiegel</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK24701_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK24701_ai__"><div class="contrib half_rhythm"><span itemprop="author">Annick Raas-Rothschild</span>, MD<div class="affiliation small">Pediatrician Medical Geneticist, Institute of Rare Diseases<br />Edmond &#x00026; Lily Safra Children's Hospital<br />Sheba Medical Center, Tel HaShomer<br />Ramat Gan, Israel</div><div class="affiliation small">Sackler School of Medicine<br />Tel Aviv University<br />Ramat Aviv, Israel<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="li.vog.htlaeh.abehs@dlihcshtor.kcinna" class="oemail">li.vog.htlaeh.abehs@dlihcshtor.kcinna</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Ronen Spiegel</span>, MD<div class="affiliation small">Pediatrician Medical Geneticist, Pediatric Department B and Genetic Institute<br />Emek Medical Center<br />Afula, Israel</div><div class="affiliation small">Rappaport Faculty of Medicine<br />Technion &#x02013; Israel Institute of Technology<br />Haifa, Israel<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="li.ten.vahaz@rlegeips" class="oemail">li.ten.vahaz@rlegeips</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">January 28, 2010</span>; Last Update: <span itemprop="dateModified">November 21, 2019</span>.</p><p><em>Estimated reading time: 19 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="ml3c.Summary" itemprop="description"><h2 id="_ml3c_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Mucolipidosis III gamma (ML III&#x003b3;) is a slowly progressive inborn error of metabolism mainly affecting skeletal, joint, and connective tissues. Clinical onset is in early childhood; the progressive course results in severe functional impairment and significant morbidity from chronic pain. Cardiorespiratory complications (restrictive lung disease from thoracic involvement, and thickening and insufficiency of the mitral and aortic valves) are rarely clinically significant. A few (probably &#x0003c;10%) <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals display mild cognitive impairment.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of ML III&#x003b3; is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with suggestive clinical and radiographic findings and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>GNPTG</i> identified on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> No measures are known to be effective in treating the progressive limitation of motion in large and small joints. Low-impact physical therapy is usually well tolerated. In older adolescents and adults joint replacement has been successful in relieving hip pain and knee pain. Carpal tunnel signs, and rarely tarsal tunnel symptoms, may require surgical tendon release procedures for temporary relief. Later in the disease course when bone pain of variable intensity may become frequent, management focuses on pain relief. Bisphosphonate treatment in patients with significant skeletal disease and markedly decreased bone mineral densitometry can be considered. When significant cardiac valvular dysfunction disrupts ventricular function, valve replacement needs to be considered. Addressing the social and emotional needs of patients and their families is recommended.</p><p><i>Surveillance:</i> Yearly outpatient clinic visits (unless more frequent pain, cardiac, and/or respiratory monitoring is warranted) to assess pain level, musculoskeletal needs, gross motor and fine motor function, vision, cardiac and respiratory function, development, educational needs, psychological issues, and utilization of community resources. Frequency of DEXA scans depends on age and results of prior studies.</p><p><i>Agents/circumstances to avoid:</i> Vigorous stretching exercises because they are ineffective, painful, and may damage the surrounding joint capsule and adjacent tendons.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>ML III&#x003b3; is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. If both parents are known to be carriers of one <i>GNPTG</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has at conception a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Once the <i>GNPTG</i> pathogenic variants in an affected family member are known, <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> for at-risk relatives, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for a pregnancy at increased risk, and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-testing/">preimplantation genetic testing</a> are possible.</p></div></div><div id="ml3c.Diagnosis"><h2 id="_ml3c_Diagnosis_">Diagnosis</h2><p>Formal diagnostic criteria for mucolipidosis III gamma have not been established.</p><div id="ml3c.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Mucolipidosis III gamma (ML III&#x003b3;) <b>should be suspected</b> in individuals with the following clinical and radiographic findings [<a class="bk_pop" href="#ml3c.REF.raasrothschild.2004.e52">Raas-Rothschild et al 2004</a>, <a class="bk_pop" href="#ml3c.REF.t_ys_z.2018.398">T&#x000fc;ys&#x000fc;z et al 2018</a>, <a class="bk_pop" href="#ml3c.REF.nampoothiri.2019.7">Nampoothiri et al 2019</a>].</p><p><b>Clinical findings</b></p><ul><li class="half_rhythm"><div>Growth rate deceleration</div></li><li class="half_rhythm"><div>Joint stiffness of the fingers, shoulders, and hips</div></li><li class="half_rhythm"><div>Gradual mild coarsening of facial features</div></li><li class="half_rhythm"><div>Genu valgum</div></li><li class="half_rhythm"><div>Spinal deformities including scoliosis and hyperlordosis</div></li><li class="half_rhythm"><div>No organomegaly</div></li></ul><p><b>Radiographic findings.</b> In early childhood, skeletal radiographs reveal mild-to-moderate dysostosis multiplex:</p><ul><li class="half_rhythm"><div><b>Pelvis and hips.</b> Hypoplastic iliac bones with flared iliac wings and shallow and irregular acetabula and moderate-to-severe dysplasia of the proximal femoral epiphyses &#x02013; giving rise to coxa valga &#x02013; are the most striking radiologic abnormalities.</div></li><li class="half_rhythm"><div><b>Hands and feet.</b> Diaphyses of metacarpals and phalanges are mildly shortened with "bullet-shaped" distal end of phalanges; carpal bones may be smaller than normal and with osteoporotic changes.</div></li><li class="half_rhythm"><div><b>Ribs.</b> Widening especially in the lateral and frontal costochondral junctions</div></li><li class="half_rhythm"><div><b>Spine.</b> Generalized platyspondyly; irregularity of the anterior upper and lower vertebral endplates; wedge-shaped and small ovoid vertebral bodies</div></li></ul><p>In late childhood or adolescence, the changes on skeletal radiographs worsen with the development of generalized osteopenia.</p></div><div id="ml3c.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of ML III&#x003b3; <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with suggestive clinical and radiographic findings and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>GNPTG</i> identified on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK24701/table/ml3c.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figml3cTmoleculargenetictestingusedin" rid-ob="figobml3cTmoleculargenetictestingusedin">Table 1</a>).</p><div id="ml3c.Molecular_Genetic_Testing"><h4>Molecular Genetic Testing</h4><p>Approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Gene-targeted testing (<b>Option 1</b>) requires that the clinician determine which gene(s) are likely involved, whereas genomic testing (<b>Option 2</b>) does not.</p><p><b>Option 1. A mucolipidosis or lysosomal storage disorders</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>GNPTG</i> and other genes of interest (see <a href="#ml3c.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>Option 2. Comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing.</b>
<b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible. If <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic, <b><a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a></b> (when clinically available) may be considered to detect (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="ml3c.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Mucolipidosis III Gamma</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK24701/table/ml3c.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml3c.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ml3c.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_ml3c.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_ml3c.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method&#x000a0;<sup>3</sup></th></tr></thead><tbody><tr><td headers="hd_h_ml3c.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>GNPTG</i></td><td headers="hd_h_ml3c.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_ml3c.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~99%%&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_ml3c.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_ml3c.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None detected</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="ml3c.TF.1.1"><p class="no_margin">See <a href="/books/NBK24701/#ml3c.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="ml3c.TF.1.2"><p class="no_margin">See <a href="#ml3c.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="ml3c.TF.1.3"><p class="no_margin">Data from <a class="bk_pop" href="#ml3c.REF.nampoothiri.2019.7">Nampoothiri et al [2019]</a>, <a class="bk_pop" href="#ml3c.REF.velho.2019.842">Velho et al [2019]</a></p></div></dd><dt>4. </dt><dd><div id="ml3c.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="ml3c.TF.1.5"><p class="no_margin">Two <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> deletions reported are of a size detectable by sequencing but could be missed due to their location [<a class="bk_pop" href="#ml3c.REF.persichetti.2009.978">Persichetti et al 2009</a>].</p></div></dd><dt>6. </dt><dd><div id="ml3c.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd></dl></div></div></div></div><div id="ml3c.Supportive_Biochemical_Findings"><h4>Supportive Biochemical Findings</h4><p><b>Activity of lysosomal hydrolases.</b> In ML III&#x003b3; the activity of nearly all lysosomal hydrolases is up to tenfold higher in serum dried blood and other body fluids (e.g., media from cultured fibroblasts or amniocytes) than in normal controls because mannose-6-phosphate, which is essential to proper targeting of lysosomal acid hydrolases to lysosomes, cannot be added adequately to the hydrolases and they are overexcreted into the extracellular space.</p><p>The following lysosomal hydrolases are of most interest as their increased activity in serum and other body fluids is relevant in the differential diagnosis of ML III and lysosomal storage disorders:</p><ul><li class="half_rhythm"><div>&#x003b2;-D-hexosaminidase (EC 3.2.1.52)</div></li><li class="half_rhythm"><div>&#x003b2;-D-glucuronidase (EC 3.2.1.31)</div></li><li class="half_rhythm"><div>&#x003b2;-D-galactosidase (EC 3.2.1.23)</div></li><li class="half_rhythm"><div>&#x003b1;-D-mannosidase (EC 3.2.1.24)</div></li></ul><p>Note: (1) The intracellular lysosomal hydrolase activity in cultured cells, such as skin fibroblasts, is low compared to control cells and permits support of the diagnosis as well. (2) ML III&#x003b3; cannot be diagnosed by assay of acid hydrolases in leukocytes. (In ML II, specific activity of lysosomal enzymes is elevated in plasma, deficient in fibroblasts, and normal in leukocytes.) (3) Biochemical testing (measurement of lysosomal hydrolase activity) does not distinguish ML III alpha/beta from ML III&#x003b3;. (4) Biochemical testing cannot be used to identify heterozygotes.</p><p><b>UDP-N-acetylglucosamine: lysosomal hydrolase N-acetylglucosamine-1-phosphotransferase enzyme</b> (also known as GlcNAc-phosphotransferase) (EC 2.7.8.17). Demonstration of deficiency of the enzyme GlcNAc-phosphotransferase, encoded by <i>GNPTAB</i> (causing <a href="/books/n/gene/ml2/"><i>GNPTAB</i>-related disorders</a>) and <i>GNPTG</i> (causing ML III&#x003b3;), confirms the diagnosis of a <i>GNPTAB</i>-related disorder and ML III&#x003b3;.</p></div></div></div><div id="ml3c.Clinical_Characteristics"><h2 id="_ml3c_Clinical_Characteristics_">Clinical Characteristics</h2><div id="ml3c.Clinical_Description"><h3>Clinical Description</h3><p>Mucolipidosis III gamma (ML III&#x003b3;) is a slowly progressive inborn error of metabolism mainly affecting skeletal, joint, and connective tissues. Clinical onset is in early childhood and the progressive course, including mild cardiac involvement, results in severe functional impairment and significant morbidity. A few (probably &#x0003c;10%) <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may display mild cognitive impairment [<a class="bk_pop" href="#ml3c.REF.nampoothiri.2019.7">Nampoothiri et al 2019</a>], but the majority do not.</p><p>The initial manifestation in most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals is joint stiffness in fingers as early as age 18 months [<a class="bk_pop" href="#ml3c.REF.t_ys_z.2018.398">T&#x000fc;ys&#x000fc;z et al 2018</a>].</p><p><b>Growth.</b> Weight and length at birth are within normal limits. Gradual slowing of growth rate begins in early childhood.</p><p>Worsening hip and knee contractures add to the poor growth rate. While frank dwarfism does not occur, the height of individuals with ML III&#x003b3; is often below the tenth centile on standard growth curves.</p><p><b>Craniofacial.</b> Dysmorphic facial features are absent or minimal in younger children. Although most individuals with ML III&#x003b3; develop coarsening of the facial features, it often occurs in the first two decades of life, which is more gradual than in ML III&#x003b1;/&#x003b2;.</p><p><b>Ophthalmologic.</b> While the corneae are clear by routine clinical inspection, opacities that do not cause ophthalmologic impairment may be appreciated by slit lamp examination in some individuals [<a class="bk_pop" href="#ml3c.REF.t_ys_z.2018.398">T&#x000fc;ys&#x000fc;z et al 2018</a>].</p><p><b>Respiratory.</b> Individuals with ML III&#x003b3; generally do not have pulmonary impairment; however, mild-to-moderate restrictive lung disease may be present in adults due to abnormalities of the spine and ribs that reduce lung capacity [<a class="bk_pop" href="#ml3c.REF.oussoren.2018.839">Oussoren et al 2018</a>].</p><p><b>Cardiovascular.</b> Individuals with ML III&#x003b3; are at risk for cardiac involvement. Although gradual thickening and subsequent mitral valve prolapse and insufficiency of the mitral and aortic valves are common from late childhood onward, cardiac function is normal in most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> adults [<a class="bk_pop" href="#ml3c.REF.oussoren.2018.839">Oussoren et al 2018</a>, <a class="bk_pop" href="#ml3c.REF.t_ys_z.2018.398">T&#x000fc;ys&#x000fc;z et al 2018</a>].</p><p><b>Gastrointestinal.</b> Hepatomegaly and splenomegaly are absent.</p><p><b>Skeletal / soft connective tissue.</b> Stiffness of finger joints, a cardinal feature, is usually the initial manifestation of the disorder. Moderate-to-severe claw-like flexion deformity of the fingers worsens with time. Limited range of motion of the shoulders is common early in the disease course. Genu valgum deformity occurs in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals early in the disease.</p><p>Hip involvement usually develops during the end of adolescence in ML III&#x003b3; (earlier in ML III&#x003b1;/&#x003b2;). Hip involvement progresses over years, finally resulting in destruction of the proximal femoral epiphyses. Limited hip mobility and lower-limb pain can be significant and may result in waddling gait with age.</p><p>Carpal tunnel syndrome develops in most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and may be clinically significant in the second and third decade [<a class="bk_pop" href="#ml3c.REF.raasrothschild.2004.e52">Raas-Rothschild et al 2004</a>, <a class="bk_pop" href="#ml3c.REF.t_ys_z.2018.398">T&#x000fc;ys&#x000fc;z et al 2018</a>, <a class="bk_pop" href="#ml3c.REF.nampoothiri.2019.7">Nampoothiri et al 2019</a>].</p><p>Spinal deformities develop over time and include scoliosis and hyperlordosis. In one individual atlantoaxial instability required corrective surgery; however, this complication is very uncommon in ML III&#x003b3; [<a class="bk_pop" href="#ml3c.REF.t_ys_z.2018.398">T&#x000fc;ys&#x000fc;z et al 2018</a>, <a class="bk_pop" href="#ml3c.REF.nampoothiri.2019.7">Nampoothiri et al 2019</a>].</p><p>Short neck reported in several individuals had no clinical significance [<a class="bk_pop" href="#ml3c.REF.t_ys_z.2018.398">T&#x000fc;ys&#x000fc;z et al 2018</a>].</p><p>Chronic pain syndrome significantly impairs the quality of life. It is common and mainly involves the hips, knees, and entire legs and sometimes the hands. Chronic pain syndrome is attributed to skeletal and connective tissue disease. In some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals spinal cord compression due to spinal stenosis (decreased diameter of the spinal canal) and vertebral osteoarthritic changes may also contribute to the chronic pain syndrome.</p><p>Osteopenia, confirmed by reduced bone mineral densitometry measured by dual x-ray absorptiometry (DEXA), is common.</p><p><b>Neuromotor development and intellect.</b> While motor milestones may be delayed, other aspects of development including language and learning skills are as expected for age. Affected children may require school assistance mostly because of physical limitations. While cognitive function is within the normal range in most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, a few individuals (probably &#x0003c;10%) have cognitive deficiency. It is still to be determined if this manifestation is related to ML III&#x003b3; given the <a class="def" href="/books/n/gene/glossary/def-item/consanguinity/">consanguinity</a> in many reported cases and the possibility of additional genetic causes.</p><p><b>Other.</b> The skin may become mildly thickened with time. Recently, scleroderma-like changes were reported in individuals with Moroccan ancestry [<a class="bk_pop" href="#ml3c.REF.zrhidri.2017.72">Zrhidri et al 2017</a>].</p></div><div id="ml3c.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>To date no correlation between severity of disease and type of <i>GNPTG</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been reported; however, predicted <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants, such as the recurrent variants <a class="figpopup" href="/books/NBK24701/table/ml3c.T.notable_gnptg_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figml3cTnotablegnptgpathogenicvariants" rid-ob="figobml3cTnotablegnptgpathogenicvariants">c.285dupC</a>, <a class="figpopup" href="/books/NBK24701/table/ml3c.T.notable_gnptg_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figml3cTnotablegnptgpathogenicvariants" rid-ob="figobml3cTnotablegnptgpathogenicvariants">c.445delG</a>, and <a class="figpopup" href="/books/NBK24701/table/ml3c.T.notable_gnptg_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figml3cTnotablegnptgpathogenicvariants" rid-ob="figobml3cTnotablegnptgpathogenicvariants">c.499dupC</a>, are associated with a severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#ml3c.REF.t_ys_z.2018.398">T&#x000fc;ys&#x000fc;z et al 2018</a>]. See <a class="figpopup" href="/books/NBK24701/table/ml3c.T.notable_gnptg_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figml3cTnotablegnptgpathogenicvariants" rid-ob="figobml3cTnotablegnptgpathogenicvariants">Table 5</a> for more details.</p></div><div id="ml3c.Nomenclature"><h3>Nomenclature</h3><p>UDP-<i>N</i>-acetylglucosamine: lysosomal hydrolase <i>N</i>-acetylglucosamine 1-phosphotransferasedeficiency disorders. This enzyme is the product of two genes: <i>GNPTAB</i>, encoding the alpha and beta subunits, and <i>GNPTG</i>, encoding the gamma subunit [<a class="bk_pop" href="#ml3c.REF.bao.1996.31437">Bao et al 1996</a>]. Pathogenic variants in:</p><ul><li class="half_rhythm"><div><i>GNPTAB</i> cause <a href="/books/n/gene/ml2/"><i>GNPTAB</i>-related disorders</a>, which include the severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of ML II and the attenuated form of ML III&#x003b1;/&#x003b2;;</div></li><li class="half_rhythm"><div><i>GNPTG</i> cause ML III&#x003b3; [<a class="bk_pop" href="#ml3c.REF.cathey.2008.512">Cathey et al 2008</a>].</div></li></ul><p>The trivial name of this enzyme is UDPGlcNAc 1-P-transferase; thus, the three ML phenotypes can be considered "UDPGlcNAc 1-P-transferase deficiency disorders" [<a class="bk_pop" href="#ml3c.REF.leroy.2007">Leroy 2007</a>].</p><p>ML III&#x003b3; was previously referred to as variant pseudo-Hurler polydystrophy* or mucolipidosis IIIC [<a class="bk_pop" href="#ml3c.REF.cathey.2008.512">Cathey et al 2008</a>].</p><p>*"Pseudo-Hurler polydystrophy" was the term used from 1966 by Maroteaux and Lamy when they first delineated ML III. They used this term because of the resemblance of ML III to Hurler disease, or mucopolysaccharidosis I (MPS I) [<a class="bk_pop" href="#ml3c.REF.kornfeld.2001">Kornfeld &#x00026; Sly 2001</a>].</p></div><div id="ml3c.Prevalence"><h3>Prevalence</h3><p>The worldwide estimated incidence of ML II, ML III&#x003b1;/&#x003b2;, and ML III&#x003b3; varies between 2.5 and 10 cases per 1,000,000 live births [<a class="bk_pop" href="#ml3c.REF.velho.2019.842">Velho et al 2019</a>]. The exact prevalence of ML III&#x003b3; is unknown; it is considered an ultra-rare disease.</p><p>Most individuals with ML III&#x003b3; known to the authors originated from the Mediterranean region [<a class="bk_pop" href="#ml3c.REF.raasrothschild.2004.e52">Raas-Rothschild et al 2004</a>, <a class="bk_pop" href="#ml3c.REF.persichetti.2009.978">Persichetti et al 2009</a>, <a class="bk_pop" href="#ml3c.REF.t_ys_z.2018.398">T&#x000fc;ys&#x000fc;z et al 2018</a>]. However, more recent reports include individuals with ML III&#x003b3; from other geographic regions including China, India, South America (Brazil), North America, and North Africa [<a class="bk_pop" href="#ml3c.REF.persichetti.2009.978">Persichetti et al 2009</a>, <a class="bk_pop" href="#ml3c.REF.gao.2011.107">Gao et al 2011</a>, <a class="bk_pop" href="#ml3c.REF.nampoothiri.2019.7">Nampoothiri et al 2019</a>, <a class="bk_pop" href="#ml3c.REF.velho.2019.842">Velho et al 2019</a>], suggesting that the disorder is pan ethnic.</p></div></div><div id="ml3c.Genetically_Related_Allelic_Disorde"><h2 id="_ml3c_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>GNPTG.</i></p></div><div id="ml3c.Differential_Diagnosis"><h2 id="_ml3c_Differential_Diagnosis_">Differential Diagnosis</h2><p>Mucolipidosis II (ML II), ML III&#x003b1;/&#x003b2;, and ML III&#x003b3; are all UDPGlcNAc 1-P-transferase deficiency disorders (see <a href="#ml3c.Nomenclature">Nomenclature</a>). Whereas the clinical phenotypes of ML III&#x003b1;/&#x003b2; and ML III&#x003b3; can be difficult to distinguish, the severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of ML II is easily differentiated. In general, the ML III&#x003b3; phenotype is less severe than ML III&#x003b1;/&#x003b2;.</p><p>See <a class="figpopup" href="/books/NBK24701/table/ml3c.T.genes_to_consider_in_the_differen/?report=objectonly" target="object" rid-figpopup="figml3cTgenestoconsiderinthedifferen" rid-ob="figobml3cTgenestoconsiderinthedifferen">Table 2</a> for inherited disorders to consider in the differential diagnosis of ML III&#x003b3;.</p><div id="ml3c.T.genes_to_consider_in_the_differen" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Genes to Consider in the Differential Diagnosis of Mucolipidosis III Gamma (ML III&#x003b3;)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK24701/table/ml3c.T.genes_to_consider_in_the_differen/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml3c.T.genes_to_consider_in_the_differen_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_1" style="text-align:center;vertical-align:middle;">Gene(s)</th><th id="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_2" style="text-align:center;vertical-align:middle;">Disorder</th><th id="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Clinical Features of Differential Diagnosis Disorder</th></tr><tr><th headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_4" id="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/ML III&#x003b3;</th><th headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_4" id="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from ML III&#x003b3;</th></tr></thead><tbody><tr><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GNPTAB</i></td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ML III&#x003b1;/&#x003b2; (see <a href="/books/n/gene/ml2/"><i>GNPTAB</i>-Related Disorders</a>)&#x000a0;<sup>1</sup></td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_4 hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical features of ML III&#x003b3; are similar to but milder than those of ML III&#x003b1;/&#x003b2;.</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_4 hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No specific ethnic predilection has been reported in ML III &#x003b1;/&#x003b2;.&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CCN6 (WISP3)</i></td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/ppr-dysp/">Progressive pseudorheumatoid dysplasia</a></td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_4 hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Joint stiffness &#x00026; osteoarthritis</div></li><li class="half_rhythm"><div>Spinal involvement (kyphoscoliosis, platyspondyly)</div></li><li class="half_rhythm"><div>Claw hands</div></li></ul>
</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_4 hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Absence of dysostosis multiplex</div></li><li class="half_rhythm"><div>Disease course less progressive</div></li><li class="half_rhythm"><div>Normal level of serum hydrolases</div></li></ul>
</td></tr><tr><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL2A1</i></td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Osteoarthritis w/mild chondrodysplasia (see <a href="/books/n/gene/collagen-2/">Type II Collagen Disorders Overview</a>)</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_4 hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Joint stiffness &#x00026; osteoarthritis</div></li><li class="half_rhythm"><div>Mild short stature</div></li></ul>
</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_4 hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Absence of dysostosis multiplex</div></li><li class="half_rhythm"><div>Disease course less progressive</div></li><li class="half_rhythm"><div>Normal level of serum hydrolases</div></li></ul>
</td></tr><tr><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CTSA</i></td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Juvenile galactosialidosis<br />(OMIM <a href="https://omim.org/entry/256540" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">256540</a>)</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_4 hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Joint stiffness</div></li><li class="half_rhythm"><div>Corneal clouding</div></li><li class="half_rhythm"><div>Cardiac abnormalities</div></li><li class="half_rhythm"><div>Facial coarseness</div></li><li class="half_rhythm"><div>Dysostosis multiplex</div></li></ul>
</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_4 hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Organomegaly</div></li><li class="half_rhythm"><div>Normal level of serum hydrolases</div></li><li class="half_rhythm"><div>&#x02191; urinary oligosaccharides</div></li></ul>
</td></tr><tr><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GLB1</i></td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MPS IV B&#x000a0;<sup>3</sup> (see <a href="/books/n/gene/gm1-ganglio/"><i>GLB1</i>-Related Disorders</a>)</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_4 hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Joint stiffness</div></li><li class="half_rhythm"><div>Corneal clouding</div></li><li class="half_rhythm"><div>Cardiac abnormalities</div></li><li class="half_rhythm"><div>Normal intelligence</div></li></ul>
</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_4 hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Short stature usually more severe (frank dwarfism)</div></li><li class="half_rhythm"><div>Absence of dysostosis multiplex</div></li><li class="half_rhythm"><div>Normal level of serum hydrolases</div></li></ul>
</td></tr><tr><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GUSB</i></td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MPS VII B&#x000a0;<sup>4</sup> (OMIM <a href="http://www.omim.org/entry/253220" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">253220</a>)</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_4 hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Dysostosis multiplex</div></li><li class="half_rhythm"><div>Spinal deformities (kyphoscoliosis)</div></li><li class="half_rhythm"><div>Coarse facies</div></li><li class="half_rhythm"><div>Corneal opacities</div></li><li class="half_rhythm"><div>Cardiac involvement</div></li></ul>
</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_4 hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Normal level of serum hydrolases</div></li></ul>
</td></tr><tr><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>IDS</i></td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Slowly progressive <a href="/books/n/gene/hunter/">MPS II</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_4 hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Joint stiffness</div></li><li class="half_rhythm"><div>Corneal clouding</div></li><li class="half_rhythm"><div>Cardiac abnormalities</div></li><li class="half_rhythm"><div>Facial coarseness</div></li><li class="half_rhythm"><div>Dysostosis multiplex</div></li></ul>
</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_4 hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Organomegaly</div></li><li class="half_rhythm"><div>Cognitive impairment</div></li><li class="half_rhythm"><div>Hearing impairment</div></li><li class="half_rhythm"><div>Normal level of serum hydrolases</div></li></ul>
</td></tr><tr><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>IDUA</i></td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Slowly progressive <a href="/books/n/gene/mps1/">MPS I</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_4 hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Joint stiffness</div></li><li class="half_rhythm"><div>Corneal clouding</div></li><li class="half_rhythm"><div>Cardiac abnormalities</div></li><li class="half_rhythm"><div>Facial coarseness</div></li><li class="half_rhythm"><div>Dysostosis multiplex</div></li></ul>
</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_4 hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Organomegaly</div></li><li class="half_rhythm"><div>Cognitive impairment</div></li><li class="half_rhythm"><div>Hearing impairment</div></li><li class="half_rhythm"><div>Normal level of serum hydrolases</div></li></ul>
</td></tr><tr><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MAN2B1</i></td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/a-mannosidosis/">Alpha-mannosidosis</a></td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_4 hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Facial coarseness</div></li><li class="half_rhythm"><div>Dysostosis multiplex</div></li></ul>
</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_4 hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Organomegaly</div></li><li class="half_rhythm"><div>Cognitive impairment</div></li><li class="half_rhythm"><div>Hearing impairment</div></li><li class="half_rhythm"><div>Normal level of serum hydrolases</div></li></ul>
</td></tr><tr><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC17A5</i></td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/issd/">Free sialic acid storage disorders</a></td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_4 hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Facial coarseness</div></li><li class="half_rhythm"><div>Skeletal abnormalities</div></li></ul>
</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_4 hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Organomegaly</div></li><li class="half_rhythm"><div>Cognitive impairment</div></li><li class="half_rhythm"><div>Neurologic abnormalities</div></li><li class="half_rhythm"><div>Normal level of serum hydrolases</div></li></ul>
</td></tr><tr><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SUMF1</i></td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/m-sulfatase-def/">Multiple sulfatase deficiency</a></td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_4 hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Joint stiffness</div></li><li class="half_rhythm"><div>Corneal clouding</div></li><li class="half_rhythm"><div>Cardiac abnormalities</div></li><li class="half_rhythm"><div>Facial coarseness</div></li><li class="half_rhythm"><div>Dysostosis multiplex</div></li></ul>
</td><td headers="hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_1_4 hd_h_ml3c.T.genes_to_consider_in_the_differen_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Organomegaly</div></li><li class="half_rhythm"><div>Neurologic abnormalities</div></li><li class="half_rhythm"><div>Cognitive impairment</div></li><li class="half_rhythm"><div>Normal level of serum hydrolases</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; ML = mucolipidosis; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; MPS = mucopolysaccharidosis; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="ml3c.TF.2.1"><p class="no_margin">Also referred to as pseudo-Hurler polydystrophy</p></div></dd><dt>2. </dt><dd><div id="ml3c.TF.2.2"><p class="no_margin">Most individuals with ML III&#x003b3; known to the authors originated from the Mediterranean region [<a class="bk_pop" href="#ml3c.REF.raasrothschild.2004.e52">Raas-Rothschild et al 2004</a>, <a class="bk_pop" href="#ml3c.REF.encarna__o.2009.76">Encarna&#x000e7;&#x000e3;o et al 2009</a>, <a class="bk_pop" href="#ml3c.REF.persichetti.2009.978">Persichetti et al 2009</a>].</p></div></dd><dt>3. </dt><dd><div id="ml3c.TF.2.3"><p class="no_margin">Also referred to as Morquio syndrome type B</p></div></dd><dt>4. </dt><dd><div id="ml3c.TF.2.4"><p class="no_margin">Also referred to as Sly disease type B</p></div></dd><dt>5. </dt><dd><div id="ml3c.TF.2.5"><p class="no_margin">Also referred to as Hunter syndrome</p></div></dd><dt>6. </dt><dd><div id="ml3c.TF.2.6"><p class="no_margin">Also referred to as Hurler-Scheie syndrome or Scheie syndrome</p></div></dd></dl></div></div></div><p><b>Other disorders to consider</b></p><ul><li class="half_rhythm"><div><b>Rheumatologic disorders</b> are often suspected in individuals with ML III&#x003b3; because of slowly decreasing range of motion in large and small joints and increasing pain in the hips [<a class="bk_pop" href="#ml3c.REF.brik.1993.133">Brik et al 1993</a>].</div></li><li class="half_rhythm"><div><b>Rheumatoid arthritis</b> (OMIM <a href="http://www.omim.org/entry/180300" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">180300</a>) presents with clinical and laboratory signs of inflammation. The activities of the several lysosomal enzymes in serum are normal. Dysostosis multiplex is absent. Family history is not compatible with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance.</div></li></ul></div><div id="ml3c.Management"><h2 id="_ml3c_Management_">Management</h2><div id="ml3c.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with mucolipidosis III gamma (ML III&#x003b3;), the evaluations summarized in <a class="figpopup" href="/books/NBK24701/table/ml3c.T.recommended_evaluations_following/?report=objectonly" target="object" rid-figpopup="figml3cTrecommendedevaluationsfollowing" rid-ob="figobml3cTrecommendedevaluationsfollowing">Table 3</a> (if not performed as part of the evaluation that led to the diagnosis) are recommended.</p><div id="ml3c.T.recommended_evaluations_following" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with Mucolipidosis III&#x003b3;</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK24701/table/ml3c.T.recommended_evaluations_following/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml3c.T.recommended_evaluations_following_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Constitutional</b></td><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Height, weight, head circumference</td><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To assess growth rate</td></tr><tr><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Skeletal</b></td><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pain assessment</td><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To assess pain scores &#x00026; involvement</td></tr><tr><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Orthopedics / physical medicine &#x00026; rehabilitation / PT / OT evaluation</td><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Incl assessment of:
<ul><li class="half_rhythm"><div>Lower limb pain (can be significant)</div></li><li class="half_rhythm"><div>Gross motor &#x00026; fine motor skills</div></li><li class="half_rhythm"><div>Hip, knee contractures</div></li><li class="half_rhythm"><div>Limited range of motion of shoulders</div></li><li class="half_rhythm"><div>Stiffness of finger joints &#x00026; Dupuytren-like palmar contractures (starting in late childhood)</div></li><li class="half_rhythm"><div>Carpal tunnel syndrome</div></li><li class="half_rhythm"><div>Odontoid dysplasia &#x00026; risk of atlanto-axial dislocation</div></li><li class="half_rhythm"><div>Mobility, activities of daily living, &#x00026; need for adaptive devices</div></li><li class="half_rhythm"><div>Need for PT (to improve gross motor skills) &#x00026;/or OT (to improve fine motor skills)</div></li></ul>
</td></tr><tr><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Complete skeletal survey</td><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To better assess skeletal involvement</td></tr><tr><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Metabolic</b><br /><b>bone disease</b></td><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DEXA study; biomarkers reflecting bone metabolism</td><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Perform baseline DEXA scan:
<ul><li class="half_rhythm"><div>Children age &#x0003e;5 yrs</div></li><li class="half_rhythm"><div>Adults at time of diagnosis</div></li></ul>
</td></tr><tr><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Development</b></td><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental assessment</td><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Incl motor, adaptive, cognitive, &#x00026; speech/language evaluation</div></li><li class="half_rhythm"><div>Evaluation for early intervention / special education</div></li></ul>
</td></tr><tr><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiac</b></td><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical examination, ECG, echocardiogram</td><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To assess for mitral &#x00026; aortic valve involvement usually beginning in late childhood</td></tr><tr><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ophthalmologic</b></td><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Visual acuity, slit lamp examination</td><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">For evidence of corneal opacities</td></tr><tr><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Respiratory</b></td><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pulmonary consultation</td><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Lung function studies to evaluate for restrictive lung disease from spine &#x00026; rib abnormalities</td></tr><tr><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Incl <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a></td></tr><tr><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Family support/resources</td><td headers="hd_h_ml3c.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess:
<ul><li class="half_rhythm"><div>Use of community or online resources (e.g., Parent to Parent)</div></li><li class="half_rhythm"><div>Need for social work involvement for parental support</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">OT = occupational therapy; PT = physical therapy</p></div></dd></dl></div></div></div></div><div id="ml3c.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Supportive and symptomatic management is indicated.</p><div id="ml3c.Musculoskeletal"><h4>Musculoskeletal</h4><p>No measures are known to be effective in treating the progressive limitation of motion in large and small joints. Physiotherapy intervention programs need to be adapted to the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's needs. Short sessions of aqua therapy that are "low impact" in regard to joint and tendon strain are usually well tolerated.</p><p>Later in the disease course, bone pain of variable intensity may become frequent. Management of pain in the hips is required. In older adolescents and adults, bilateral hip replacement has been successful. In patients with progressive knee involvement, knee replacement has been successful.</p><p>Casts (especially of the hands) during the night hours are usually well tolerated and appear to improve daily functions.</p><p>Carpal tunnel signs, and rarely tarsal tunnel symptoms, may require surgical tendon release procedures for temporary relief [<a class="bk_pop" href="#ml3c.REF.oussoren.2018.839">Oussoren et al 2018</a>, <a class="bk_pop" href="#ml3c.REF.t_ys_z.2018.398">T&#x000fc;ys&#x000fc;z et al 2018</a>].</p><p>In cases with severe spinal deformities with or without spinal cord compression, spinal surgical procedures should be considered.</p><p>Routine pain assessment and consultation with a pain specialist should be performed as required.</p><p>Of note, in patients with significant skeletal disease and considerable decrease in bone mineral densitometry (Z score&#x0003c;-2.5), bisphosphonates (oral or intravenous) should be highly considered [<a class="bk_pop" href="#ml3c.REF.t_ys_z.2018.398">T&#x000fc;ys&#x000fc;z et al 2018</a>; T&#x000fc;ys&#x000fc;z, personal communication].</p></div><div id="ml3c.Cardiac"><h4>Cardiac</h4><p>When significant valvular dysfunction disrupts ventricular function, valve replacement should be seriously considered. However, such complications are rare in ML III&#x003b3;.</p><p>Antibiotic prophylaxis before minor and major surgical procedures (including dental procedures) is appropriate to prevent bacterial endocarditis.</p><p>Psychosocial support of patients and families is recommended.</p></div><div id="ml3c.Anesthesia"><h4>Anesthesia</h4><p>As with all storage diseases, anesthesia for individuals with ML III&#x003b3; must be well planned. Because of concerns about airway management, surgical intervention should be undertaken only in tertiary care settings with pediatric anesthesiologists and intensive care physicians.</p><p>The anesthetic team should be aware of the following issues:</p><ul><li class="half_rhythm"><div>Persons with ML III&#x003b3; are small and have a small airway, reduced tracheal suppleness from stiff connective tissue, and progressive narrowing of the airway from mucosal thickening. The use of a smaller endotracheal tube than for age- and size-matched controls is necessary.</div></li><li class="half_rhythm"><div>Fiberoptic intubation must be available.</div></li><li class="half_rhythm"><div>Persons with ML III&#x003b3; have short necks, and atlanto-axial instability has been reported [<a class="bk_pop" href="#ml3c.REF.t_ys_z.2018.398">T&#x000fc;ys&#x000fc;z et al 2018</a>].</div></li><li class="half_rhythm"><div>Jaw and neck movement can be limited.</div></li><li class="half_rhythm"><div>Abnormalities of the spine and ribs can limit the individual's capacity to breathe and fully expand the lungs.</div></li></ul></div></div><div id="ml3c.Surveillance"><h3>Surveillance</h3><div id="ml3c.T.recommended_surveillance_for_indi" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with Mucolipidosis III&#x003b3;</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK24701/table/ml3c.T.recommended_surveillance_for_indi/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml3c.T.recommended_surveillance_for_indi_lrgtbl__"><table><thead><tr><th id="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency</th></tr></thead><tbody><tr><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Constitutional</b></td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Height, weight, head circumference</td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Yearly</td></tr><tr><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Pain</b></td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment of pain level by pain specialist</td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Yearly</td></tr><tr><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment of range of motion, stiffness &#x00026; contractures, carpal tunnel syndrome, tarsal tunnel syndrome, activities of daily living</td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Yearly</td></tr><tr><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Mobility</b></td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">By physical therapist, physiatrist</td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Yearly</td></tr><tr><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Fine motor skills</b></td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">By occupational therapist</td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Yearly</td></tr><tr><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Metabolic</b><br /><b>bone disease</b></td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DEXA scan</td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Children: 5-yr intervals after baseline study</div></li><li class="half_rhythm"><div>Adults w/normal studies: 3-yr intervals</div></li><li class="half_rhythm"><div>Adolescents &#x00026; adults w/&#x02193; densitometry: 2-yr intervals</div></li></ul>
</td></tr><tr><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Respiratory</b></td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Lung function studies</td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5-yr intervals</td></tr><tr><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiac</b></td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cardiac evaluation incl echocardiography</td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Yearly</td></tr><tr><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ophthalmologic</b></td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitor visual acuity &#x00026; corneal opacities.</td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Yearly</td></tr><tr><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Development/</b><br /><b>School issues</b></td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">General evaluation</td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Yearly</td></tr><tr><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Educational</b><br /><b>resources</b></td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">General evaluation</td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Yearly</td></tr><tr><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Psychological</b><br /><b>issues</b></td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">General evaluation</td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Yearly</td></tr><tr><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Community</b><br /><b>resources</b></td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">General evaluation</td><td headers="hd_h_ml3c.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Yearly</td></tr></tbody></table></div></div></div><div id="ml3c.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Vigorous stretching exercises are not recommended because they are ineffective, painful, and may damage the surrounding joint capsule and adjacent tendons.</p></div><div id="ml3c.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#ml3c.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="ml3c.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="ml3c.Genetic_Counseling"><h2 id="_ml3c_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="ml3c.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Mucolipidosis III gamma (ML III&#x003b3;) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="ml3c.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div class="half_rhythm">The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are typically heterozygotes (i.e., carriers of one <i>GNPTG</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div class="half_rhythm">Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> to confirm that each parent is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>GNPTG</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and to allow for reliable <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> assessment. (<i>De novo</i> variants are known to occur at a low but appreciable rate in <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorders [<a class="bk_pop" href="#ml3c.REF.j_nsson.2017.519">J&#x000f3;nsson et al 2017</a>].)</div><div class="half_rhythm">In one family, only the father of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> was found to be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>GNPTG</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (a <i>GNPTG</i> pathogenic variant was not detected in maternal DNA) and the proband was presumed to have ML III&#x003b3; as the result of one inherited and one <i>de novo GNPTG</i> pathogenic variant [<a class="bk_pop" href="#ml3c.REF.ludwig.2017.92">Ludwig et al 2017</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>If each parent is known to be a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of one <i>GNPTG</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has at conception a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with ML III&#x003b3; are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>GNPTG</i>.</p><p><b>Other family members.</b> If each parent is a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of one <i>GNPTG</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents are at a 50% risk of being carriers of a <i>GNPTG</i> pathogenic variant.</p></div><div id="ml3c.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p><b>Molecular genetic testing.</b> Carrier testing for at-risk relatives requires prior identification of the <i>GNPTG</i> pathogenic variants in the family.</p><p>Note: Biochemical testing cannot be used to identify heterozygotes.</p></div><div id="ml3c.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="ml3c.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Testing</h3><p><b>Molecular genetic testing.</b> Once the <i>GNPTG</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-testing/">preimplantation genetic testing</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="ml3c.Resources"><h2 id="_ml3c_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=mucolipidosisiiigamma" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Mucolipidosis III gamma</a></div></li><li class="half_rhythm"><div><b>Vaincre les Maladies Lysosomales</b></div><div>2 Ter Avenue De France</div><div>Massy 91300</div><div>France</div><div><b>Phone:</b> (0033) 1 69 75 40 30</div><div><b>Fax:</b> (0033)1 60 11 15 83</div><div><b>Email:</b> vml@vml-asso.org</div><div><a href="http://www.vml-asso.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Vaincre les Maladies Lysosomales</a></div></li><li class="half_rhythm"><div><b>International Advocate for Glycoprotein Storage Diseases (ISMRD)</b></div><div>3921 Country Club Drive</div><div>Lakewood CA 90712</div><div><b>Email:</b> info@ismrd.org</div><div><a href="http://www.ismrd.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ismrd.org</a></div></li><li class="half_rhythm"><div><b>National MPS Society</b></div><div>PO Box 14686</div><div>Durham NC 27709-4686</div><div><b>Phone:</b> 877-677-1001 (toll-free); 919-806-0101</div><div><b>Fax:</b> 919-806-2055</div><div><b>Email:</b> info@mpssociety.org</div><div><a href="http://www.mpssociety.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mpssociety.org</a></div></li><li class="half_rhythm"><div><b>Society for Mucopolysaccharide Diseases (MPS)</b></div><div>MPS House Repton Place</div><div>White Lion Road</div><div>Amersham Buckinghamshire HP7 9LP</div><div>United Kingdom</div><div><b>Phone:</b> 0345 389 9901</div><div><b>Email:</b> mps@mpssociety.co.uk</div><div><a href="http://www.mpssociety.co.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mpssociety.co.uk</a></div></li></ul></div><div id="ml3c.Molecular_Genetics"><h2 id="_ml3c_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="ml3c.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Mucolipidosis III Gamma: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK24701/table/ml3c.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml3c.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_ml3c.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_ml3c.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_ml3c.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_ml3c.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_ml3c.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_ml3c.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_ml3c.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/84572" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>GNPTG</i></a></td><td headers="hd_b_ml3c.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=84572" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">16p13<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_ml3c.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9UJJ9" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">N-acetylglucosamine-1-phosphotransferase subunit gamma</a></td><td headers="hd_b_ml3c.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/GNPTG" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GNPTG @ LOVD</a></td><td headers="hd_b_ml3c.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=GNPTG" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GNPTG</a></td><td headers="hd_b_ml3c.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=GNPTG[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GNPTG</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="ml3c.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="ml3c.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Mucolipidosis III Gamma (<a href="/omim/252605,607838" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK24701/table/ml3c.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml3c.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/252605" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">252605</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MUCOLIPIDOSIS III GAMMA</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607838" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607838</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE, GAMMA SUBUNIT; GNPTG</td></tr></tbody></table></div></div><div id="ml3c.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>N-acetylglucosamine-1-phosphotransferase is a hexameric enzyme complex composed of two alpha, two beta, and two gamma subunits. The membrane-bound alpha and beta subunits are synthesized as a common alpha/beta precursor encoded by <i>GNPTAB</i>, whereas the soluble gamma subunit is encoded by <i>GNPTG</i>.</p><p>In the Golgi apparatus the gamma subunit directly binds to the alpha subunit and enhances N-acetylglucosamine-1-phosphotransferase activity for mannose-6-phosphate (M6P) modification of specific lysosomal enzymes. Once modified with M6P, the lysosomal hydrolases can attach to the M6P receptor and be targeted to the mature lysosome.</p><p><b>Mechanism of disease causation.</b> ML IIIy occurs by a <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> mechanism. Most disease-associated variants are predicted to be loss-of-function variants. The majority of reported <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants are located in the M6P receptor homology (MRH) <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>. It is speculated that these variants impair MRH domain function, which plays a major role in binding phosphorylated and non-phosphorylated high-mannose-type N-glycans.</p><div id="ml3c.T.notable_gnptg_pathogenic_variants" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Notable <i>GNPTG</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK24701/table/ml3c.T.notable_gnptg_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml3c.T.notable_gnptg_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th><th id="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide<br />Change</th><th id="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein<br />Change</th><th id="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment [Reference]</th></tr></thead><tbody><tr><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_1" rowspan="9" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nucleotide/42476109" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_032520<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/14249738" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_115909<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.196C&#x0003e;T</td><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg66Ter</td><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a class="bk_pop" href="#ml3c.REF.raasrothschild.2004.e52">Raas-Rothschild et al [2004]</a>, <a class="bk_pop" href="#ml3c.REF.zrhidri.2017.72">Zrhidri et al [2017]</a>, <a class="bk_pop" href="#ml3c.REF.t_ys_z.2018.398">T&#x000fc;ys&#x000fc;z et al [2018]</a></td></tr><tr><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.285dupC</td><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe96LeufsTer32</td><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="#ml3c.GenotypePhenotype_Correlations">Genotype-phenotype correlation</a> [<a class="bk_pop" href="#ml3c.REF.t_ys_z.2018.398">T&#x000fc;ys&#x000fc;z et al 2018</a>]</td></tr><tr><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.318-1G&#x0003e;C</td><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val107TrpfsTer24</td><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a class="bk_pop" href="#ml3c.REF.raasrothschild.2004.e52">Raas-Rothschild et al [2004]</a>, <a class="bk_pop" href="#ml3c.REF.oussoren.2018.839">Oussoren et al [2018]</a></td></tr><tr><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.316G&#x0003e;A</td><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly106Ser</td><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a class="bk_pop" href="#ml3c.REF.raasrothschild.2004.e52">Raas-Rothschild et al [2004]</a>, <a class="bk_pop" href="#ml3c.REF.persichetti.2009.978">Persichetti et al [2009]</a>, <a class="bk_pop" href="#ml3c.REF.gheldof.2019.e00527">Gheldof et al [2019]</a></td></tr><tr><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.333G&#x0003e;A</td><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp111Ter</td><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a class="bk_pop" href="#ml3c.REF.persichetti.2009.978">Persichetti et al [2009]</a>, <a class="bk_pop" href="#ml3c.REF.cagle.2016.s34">Cagle [2016]</a></td></tr><tr><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.347_349delACA</td><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn116del</td><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a class="bk_pop" href="#ml3c.REF.tiede.2004.535">Tiede et al [2004]</a>, <a class="bk_pop" href="#ml3c.REF.persichetti.2009.978">Persichetti et al [2009]</a>, <a class="bk_pop" href="#ml3c.REF.t_ys_z.2018.398">T&#x000fc;ys&#x000fc;z et al [2018]</a></td></tr><tr><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.445delG</td><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala149ProfsTer13</td><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="#ml3c.GenotypePhenotype_Correlations">Genotype-phenotype correlation</a> [<a class="bk_pop" href="#ml3c.REF.raasrothschild.2004.e52">Raas-Rothschild et al 2004</a>, <a class="bk_pop" href="#ml3c.REF.t_ys_z.2018.398">T&#x000fc;ys&#x000fc;z et al 2018</a>]</td></tr><tr><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.499dupC</td><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu167ProfsTer32</td><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="#ml3c.GenotypePhenotype_Correlations">Genotype-phenotype correlation</a> [<a class="bk_pop" href="#ml3c.REF.raasrothschild.2000.673">Raas-Rothschild et al 2000</a>, <a class="bk_pop" href="#ml3c.REF.t_ys_z.2018.398">T&#x000fc;ys&#x000fc;z et al 2018</a>]</td></tr><tr><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.857C&#x0003e;T</td><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr286Met</td><td headers="hd_h_ml3c.T.notable_gnptg_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a class="bk_pop" href="#ml3c.REF.persichetti.2009.978">Persichetti et al [2009]</a>, <a class="bk_pop" href="#ml3c.REF.fern_ndezmarmiesse.2014.59">Fern&#x000e1;ndez-Marmiesse et al [2014]</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been reported in more than one publication and in more than one population, reflecting a possible <a class="def" href="/books/n/gene/glossary/def-item/hot-spot/">hot spot</a>.</p></div></dd><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div></div></div><div id="ml3c.References"><h2 id="_ml3c_References_">References</h2><div id="ml3c.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="ml3c.REF.bao.1996.31437">Bao M, Booth JL, Elmendorf BJ, Canfield WM. Bovine UDP-N-acetylglucosamine:lysosomal-enzyme N-acetylglucosamine-1-phosphotransferase. I. Purification and subunit structure. <span><span class="ref-journal">J Biol Chem. </span>1996;<span class="ref-vol">271</span>:31437–45.</span> [<a href="/pubmed/8940155" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8940155</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml3c.REF.brik.1993.133">Brik R, Mandel H, Aizin A, Goldscher D, Ziegler M, Bialik V, Berant M. Mucolipidosis III presenting as a rheumatological disorder. <span><span class="ref-journal">J Rheumatol. </span>1993;<span class="ref-vol">20</span>:133–6.</span> [<a href="/pubmed/8441145" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8441145</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml3c.REF.cagle.2016.s34">Cagle S. A case report of a Hispanic male with mucolipidosis III gamma with mild disease in the presence of a homozygous nonsense mutation. <span><span class="ref-journal">Mol Genet Metab. </span>2016;<span class="ref-vol">120</span>:S34.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="ml3c.REF.cathey.2008.512">Cathey SS, Kudo M, Tiede S, Raas-Rothschild A, Braulke T, Beck M, Taylor HA, Canfield WM, Leroy JG, Neufeld EF, McKusick VA. Molecular order in mucolipidosis II and III nomenclature. <span><span class="ref-journal">Am J Med Genet A. </span>2008;<span class="ref-vol">146A</span>:512–3.</span> [<a href="/pubmed/18203164" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18203164</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml3c.REF.encarna__o.2009.76">Encarna&#x000e7;&#x000e3;o M, Lacerda L, Costa R, Prata MJ, Coutinho MF, Ribeiro H, Lopes L, Pineda M, Ignatius J, Galvez H, Mustonen A, Vieira P, Lima MR, Alves S. Molecular analysis of the GNPTAB and GNPTG genes in 13 patients with mucolipidosis type II or type III - identification of eight novel mutations. <span><span class="ref-journal">Clin Genet. </span>2009;<span class="ref-vol">76</span>:76–84.</span> [<a href="/pubmed/19659762" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19659762</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml3c.REF.fern_ndezmarmiesse.2014.59">Fern&#x000e1;ndez-Marmiesse A, Morey M, Pineda M, Eiris J, Couce ML, Castro-Gago M, Fraga JM, Lacerda L, Gouveia S, P&#x000e9;rez-Poyato MS, Armstrong J, Casti&#x000f1;eiras D, Cocho JA. Assessment of a targeted resequencing assay as a support tool in the diagnosis of lysosomal storage disorders. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2014;<span class="ref-vol">9</span>:59.</span> [<a href="/pmc/articles/PMC4024120/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4024120</span></a>] [<a href="/pubmed/24767253" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24767253</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml3c.REF.gao.2011.107">Gao Y, Yang K, Xu S, Wang C, Liu J, Zhang Z, Yuan M, Luo X, Liu M, Wang QK, Liu JY. Identification of compound heterozygous mutations in GNPTG in three siblings of a Chinese family with mucolipidosis type III gamma. <span><span class="ref-journal">Mol Genet Metab. </span>2011;<span class="ref-vol">102</span>:107–9.</span> [<a href="/pubmed/20951619" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20951619</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml3c.REF.gheldof.2019.e00527">Gheldof A, Seneca S, Stouffs K, Lissens W, Jansen A, Laeremans H, Verloo P, Schoonjans AS, Meuwissen M, Barca D, Martens G, De Meirleir L. Clinical implementation of gene panel testing for lysosomal storage diseases. <span><span class="ref-journal">Mol Genet Genomic Med. </span>2019;<span class="ref-vol">7</span>:e00527</span> [<a href="/pmc/articles/PMC6393649/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6393649</span></a>] [<a href="/pubmed/30548430" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30548430</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml3c.REF.j_nsson.2017.519">J&#x000f3;nsson H, Sulem P, Kehr B, Kristmundsdottir S, Zink F, Hjartarson E, Hardarson MT, Hjorleifsson KE, Eggertsson HP, Gudjonsson SA, Ward LD, Arnadottir GA, Helgason EA, Helgason H, Gylfason A, Jonasdottir A, Jonasdottir A, Rafnar T, Frigge M, Stacey SN, Th Magnusson O, Thorsteinsdottir U, Masson G, Kong A, Halldorsson BV, Helgason A, Gudbjartsson DF, Stefansson K. Parental influence on human germline de novo mutations in 1,548 trios from Iceland. <span><span class="ref-journal">Nature. </span>2017;<span class="ref-vol">549</span>:519–22.</span> [<a href="/pubmed/28959963" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28959963</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml3c.REF.kornfeld.2001">Kornfeld S, Sly WS. I-Cell disease and pseudo-Hurler polydystrophy: disorders of lysosomal enzyme phosphorylation and localization. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Vogelstein B, eds. <em>The Metabolic and Molecular Bases of Inherited Disease</em>. 8 ed. Vol 3. New York, NY: McGraw-Hill; 2001:3469-82.</div></li><li class="half_rhythm"><div class="bk_ref" id="ml3c.REF.leroy.2007">Leroy JG. Oligosaccharidoses, disorders allied to the oligosaccharides. In: Rimoin DL, Connor JM, Pyeritz RE, Korf BR, eds. <em>Emery and Rimoin's Principles and Practice of Medical Genetics</em>. 5 ed. Philadelphia, PA: Churchill Livingstone Elsevier; 2007:2413-48.</div></li><li class="half_rhythm"><div class="bk_ref" id="ml3c.REF.ludwig.2017.92">Ludwig NF, Sperb-Ludwig F, Velho RV, Schwartz IVD. Next-generation sequencing corroborates a probable de novo GNPTG variation previously detected by Sanger sequencing. <span><span class="ref-journal">Mol Genet Metab Rep. </span>2017;<span class="ref-vol">11</span>:92–3.</span> [<a href="/pmc/articles/PMC5470938/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5470938</span></a>] [<a href="/pubmed/28649512" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28649512</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml3c.REF.nampoothiri.2019.7">Nampoothiri S, Elcioglu NH, Koca SS, Yesodharan D, Kk C, Krishnan V 5th, Bhat M, Mohandas Nair K, Radhakrishnan N, Kappanayil M, Sheth JJ, Alves S, Coutinho F, Friez MJ, Pauli RM, Unger S, Superti-Furga A, Leroy JG, Cathey SS. Does the clinical phenotype of mucolipidosis-III&#x003b3; differ from its &#x003b1;&#x003b2; counterpart? supporting facts in a cohort of 18 patients. <span><span class="ref-journal">Clin Dysmorphol. </span>2019;<span class="ref-vol">28</span>:7–16.</span> [<a href="/pubmed/30507725" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30507725</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml3c.REF.oussoren.2018.839">Oussoren E, van Eerd D, Murphy E, Lachmann R, van der Meijden JC, Hoefsloot LH, Verdijk R, Ruijter GJG, Maas M, Hollak CEM, Langendonk JG, van der Ploeg AT, Langeveld M. Mucolipidosis type III, a series of adult patients. <span><span class="ref-journal">J Inherit Metab Dis. </span>2018;<span class="ref-vol">41</span>:839–48.</span> [<a href="/pmc/articles/PMC6133174/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6133174</span></a>] [<a href="/pubmed/29704188" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29704188</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml3c.REF.persichetti.2009.978">Persichetti E, Chuzhanova NA, Dardis A, Tappino B, Pohl S, Thomas NS, Rosano C, Balducci C, Paciotti S, Dominissini S, Montalvo AL, Sibilio M, Parini R, Rigoldi M, Di Rocco M, Parenti G, Orlacchio A, Bembi B, Cooper DN, Filocamo M, Beccari T. Identification and molecular characterization of six novel mutations in the UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTG) gene in patients with mucolipidosis III gamma. <span><span class="ref-journal">Hum Mutat. </span>2009;<span class="ref-vol">30</span>:978–84.</span> [<a href="/pubmed/19370764" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19370764</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml3c.REF.raasrothschild.2004.e52">Raas-Rothschild A, Bargal R, Goldman O, Ben-Asher E, Groener JE, Toutain A, Stemmer E, Ben-Neriah Z, Flusser H, Beemer FA, Penttinen M, Olender T, Rein AJ, Bach G, Zeigler M. Genomic organisation of the UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTAG) and its mutations in mucolipidosis III. <span><span class="ref-journal">J Med Genet. </span>2004;<span class="ref-vol">41</span>:e52</span> [<a href="/pmc/articles/PMC1735719/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735719</span></a>] [<a href="/pubmed/15060128" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15060128</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml3c.REF.raasrothschild.2000.673">Raas-Rothschild A, Cormier-Daire V, Bao M, Genin E, Salomon R, Brewer K, Zeigler M, Mandel H, Toth S, Roe B, Munnich A, Canfield WM. Molecular basis of variant pseudo-hurler polydystrophy (mucolipidosis IIIC). <span><span class="ref-journal">J Clin Invest. </span>2000;<span class="ref-vol">105</span>:673–81.</span> [<a href="/pmc/articles/PMC289169/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC289169</span></a>] [<a href="/pubmed/10712439" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10712439</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml3c.REF.tiede.2004.535">Tiede S, Cantz M, Raas-Rothschild A, Muschol N, B&#x000fc;rger F, Ullrich K, Braulke T. A novel mutation in UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTAG) in two siblings with mucolipidosis type III alters a used glycosylation site. <span><span class="ref-journal">Hum Mutat. </span>2004;<span class="ref-vol">24</span>:535.</span> [<a href="/pubmed/15532026" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15532026</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml3c.REF.t_ys_z.2018.398">T&#x000fc;ys&#x000fc;z B, Kasap&#x000e7;opur &#x000d6;, Alkaya DU, &#x0015e;ahin S, S&#x000f6;zeri B, Ye&#x0015f;il G. Mucolipidosis type III gamma: three novel mutation and genotype-phenotype study in eleven patients. <span><span class="ref-journal">Gene. </span>2018;<span class="ref-vol">642</span>:398–407.</span> [<a href="/pubmed/29170090" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29170090</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml3c.REF.velho.2019.842">Velho RV, Harms FL, Danyukova T, Ludwig NF, Friez MJ, Cathey SS, Filocamo M, Tappino B, G&#x000fc;ne&#x0015f; N, T&#x000fc;ys&#x000fc;z B, Tylee KL, Brammeier KL, Heptinstall L, Oussoren E, van der Ploeg AT, Petersen C, Alves S, Saavedra GD, Schwartz IV, Muschol N, Kutsche K, Pohl S. The lysosomal storage disorders mucolipidosis type II, type III alpha/beta, and type III gamma: update on GNPTAB and GNPTG mutations. <span><span class="ref-journal">Hum Mutat. </span>2019;<span class="ref-vol">70</span>:842–64.</span> [<a href="/pubmed/30882951" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30882951</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ml3c.REF.zrhidri.2017.72">Zrhidri A, Amasdl S, Lyahyai J, Elouardi H, Chkirate B, Raymond L, Eg&#x000e9;a G, Taoudi M, El Mouatassim S, Sefiani A. Next generation sequencing identifies mutations in GNPTG gene as a cause of familial form of scleroderma-like disease. <span><span class="ref-journal">Pediatr Rheumatol Online J. </span>2017;<span class="ref-vol">15</span>:72.</span> [<a href="/pmc/articles/PMC5615433/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5615433</span></a>] [<a href="/pubmed/28950892" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28950892</span></a>]</div></li></ul></div></div><div id="ml3c.Chapter_Notes"><h2 id="_ml3c_Chapter_Notes_">Chapter Notes</h2><div id="ml3c.Acknowledgments"><h3>Acknowledgments</h3><p>We thank the "Vaincre les Maladies Lysosomales" association for their continuous support and for the research grants for our research projects on ML III gamma and ML II.</p><p>We thank the families for their cooperation.</p></div><div id="ml3c.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>21 November 2019 (bp) Comprehensive update posted live</div></li><li class="half_rhythm"><div>5 July 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>29 September 2011 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, UPD, and prenatal testing available clinically</div></li><li class="half_rhythm"><div>28 January 2010 (me) Review posted live</div></li><li class="half_rhythm"><div>28 August 2009 (arr) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK24701</span><span class="label">PMID: <a href="/pubmed/20301784" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301784</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ml3a/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ml4/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK24701&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK24701/?report=reader">PubReader</a></li><li><a href="/books/NBK24701/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK24701" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK24701" style="display:none" title="Cite this Page"><div class="bk_tt">Raas-Rothschild A, Spiegel R. Mucolipidosis III Gamma. 2010 Jan 28 [Updated 2019 Nov 21]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK24701/pdf/Bookshelf_NBK24701.pdf">PDF version of this page</a> (467K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#ml3c.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#ml3c.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#ml3c.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#ml3c.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#ml3c.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#ml3c.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#ml3c.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#ml3c.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#ml3c.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#ml3c.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#ml3c.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=84572[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">GNPTG</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK24701+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1949152" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1949152" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1949152" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1949152" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301728" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">GNPTAB</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">GNPTAB</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Leroy JG, Cathey SS, Friez MJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301730" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mucolipidosis III Alpha/Beta</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mucolipidosis III Alpha/Beta<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Leroy JG, Cathey SS, Friez MJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301341" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mucopolysaccharidosis Type I</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mucopolysaccharidosis Type I<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Clarke LA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301446" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Gaucher Disease</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Gaucher Disease<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Pastores GM, Hughes DA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23844448" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mucopolysaccharidosis Type IVA</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mucopolysaccharidosis Type IVA<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Regier DS, Oetgen M, Tanpaiboon P. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301784" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301784" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040ccb75f66d18aa8d04f7">Mucolipidosis III Gamma - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Mucolipidosis III Gamma - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:28:43-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8C73A1E03F74A10000000007EB02E2&amp;ncbi_session=CE8C73A1E040CCB1_2027SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK24701%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK24701&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK24701/&amp;ncbi_pagename=Mucolipidosis III Gamma - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C73A1E040CCB1_2027SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>